9:37
Stereotactic Body Radiation Therapy Group (SEOR)
The major efficiency of the treatment, the decrease of side effects and the improvement in the quality of life in the cancer patients will constitute the principal contributions of the linear accelerator TrueBeamSTx of the Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA). It will start treatments next autumn.
The new equipment is "extremely versatile", with aptitude to attend from the "simpler and conventional" treatments up to the "more complexes" as the SBRT.
The TrueBeamSTx will do the radiations more accurate, more rapid and less aggressive and will facilitate the reduction of 1 or 2 centimeters to 1 or 2 millimeters in the treatment zone of oncological processes and will code the percentages of treatment success in 90 % in some cases opposite to 0 previous %.
Posted in: 
